吉林敖东：公司高度关注医药行业集采常态化及创新药发展趋势

Group 1 - The company is closely monitoring the normalization of centralized procurement in the pharmaceutical industry and the trends in innovative drug development [2] - The company is focusing on its core pharmaceutical business and continuously promoting product innovation and research and development [2] - The company plans to leverage its advantages across the entire pharmaceutical industry chain to strategically manage R&D investments and carefully assess the direction and pace of innovative drug development [2]